Hyperkalemia in patients with cirrhosis and acute-on-chronic liver failure.

Dig Liver Dis

GI/Liver Unit Hospital Clinic, Barcelona, Spain; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS) y Centro de Investigaciones en Red Hepaticas y Digestivas (CIBERehd), Spain; Faculty of Medicine, University of Barcelona, Villarroel 170, Esc 3-2, Barcelona 08036, Spain. Electronic address:

Published: July 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2021.03.018DOI Listing

Publication Analysis

Top Keywords

hyperkalemia patients
4
patients cirrhosis
4
cirrhosis acute-on-chronic
4
acute-on-chronic liver
4
liver failure
4
hyperkalemia
1
cirrhosis
1
acute-on-chronic
1
liver
1
failure
1

Similar Publications

Background: An initial decline in estimated glomerular filtration rate (eGFR) often leads to reluctance to continue life-saving therapies in patients with heart failure (HF).

Objectives: The goal of this study was to describe the association between initial decline in eGFR and subsequent clinical outcomes in patients randomized to placebo or finerenone.

Methods: In this prespecified analysis of FINEARTS-HF (Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients with Heart Failure), we examined the association between initial decline in eGFR (≥15%) from randomization to 1 month and subsequent outcomes in patients assigned to finerenone or placebo.

View Article and Find Full Text PDF

Renal Outcomes With Renin-Angiotensin System Blockers After Unilateral Nephrectomy.

Kidney Int Rep

January 2025

Division of Nephrology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Introduction: Despite the benefits of renin-angiotensin system (RAS) blockers, their immediate use after nephrectomy has been limited because of concerns about impaired renal adaptation. We aimed to evaluate the effect of RAS blockers immediately after unilateral nephrectomy on renal adaptation.

Methods: This single-center retrospective cohort study included 580 patients who underwent elective unilateral nephrectomy between 2010 and 2020 and had preexisting hypertension with antihypertensive medications.

View Article and Find Full Text PDF

Background: Hyperkalemia, generally defined as serum potassium levels greater than 5.0 mEq/L, poses significant clinical risks, including cardiac toxicity and muscle weakness. Its prevalence and severity increase in patients with chronic kidney disease (CKD), diabetes mellitus, and heart failure (HF), particularly when compounded by medications like Angiotensin converting inhibitors, Angiotensin receptor blockers, and potassium sparing diuretics.

View Article and Find Full Text PDF

Rationale: As a rare cause of femoral neck fracture, usually, hyperparathyroidism is missed diagnosed by orthopedist. Patient can present with various disappearance of clinical manifestations. Primary hyperparathyroidism in senile male population is commonly an asymptomatic disorder discovered incidentally through routine lab testing.

View Article and Find Full Text PDF

Agreement between methods to assess potassium intake in patients with chronic kidney disease.

Clin Nutr ESPEN

January 2025

Post Graduation Program in Medical Science, Rio de Janeiro State University, Rio de Janeiro, 20550-900, Brazil; Department of Applied Nutrition, Nutrition Institute, Rio de Janeiro State University, Rio de Janeiro, 20550-900, Brazil. Electronic address:

Background & Aims: In the general population, 24-hour urine potassium excretion is considered the reference standard for estimating potassium intake. However, its agreement with food records and spot urine collections in adults living with chronic kidney disease (CKD) is not well-established. Given the risk of hyperkalemia related to changes in renal potassium handling, understanding if this reference standard is appropriate for the CKD population is important.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!